logo

Acelrx Pharmaceuticals Inc. (ACRX)



Trade ACRX now with
  Date
  Headline
6/4/2020 9:34:53 AM Melinta Therapeutics Plans To Acquire Tetraphase Pharmaceuticals
5/29/2020 8:34:43 AM AcelRx Pharma Announces Revised Merger Agreement With Tetraphase
4/30/2020 6:12:33 AM AcelRx Says DSUVIA Achieved Milestone C Approval
3/16/2020 7:37:30 AM AcelRx Pharma Q4 Net Loss $14.4 Mln Or $0.18/shr Vs $12.6 Mln Or $0.18/shr Prior Year
3/16/2020 7:33:10 AM AcelRx To Acquire Tetraphase In Stock For Stock $14.4 Mln Deal
11/13/2019 7:04:02 AM AcelRx Pharma Announces Publication Analyzing Pooled Dosing And Efficacy Data On Sufentanil Sublingual 30 Mcg Tablets
6/3/2019 7:07:57 AM AcelRx Closes $25 Mln Senior Secured Debt Facility
5/8/2019 4:02:39 PM AcelRx Pharma Q1 Loss/share $0.17 Vs. Loss $0.23 Year Ago
1/7/2019 8:37:10 AM AcelRx Publishes Data On Sufentanil Sublingual Tablets For Short-term Treatment Of Moderate-to-severe Acute Pain
11/9/2018 9:13:45 AM AcelRx Pharma Prices Public Offering Of 12.70 Mln Shares At $3.15/shr
11/9/2018 7:09:05 AM AcelRx Intends To Offer And Sell Proposed Public Offering Of Common Stock
10/12/2018 7:13:33 AM AcelRx Stock Trading Halted; FDA Advisory Committee To Review DSUVIA New Drug Application